Last Updated on October 11, 2024 by The Health Master
New Delhi: Zydus Lifesciences said it has received approval from the US health regulator to market a generic drug used to treat certain stomach and esophagus problems.
The company has received approval from US Food and Drug Administration (USFDA) to market Esomeprazole Magnesium for delayed-release oral suspension in 20 mg and 40 mg strengths in the American market, the drug maker said in a statement.
Esomeprazole is used to treat certain stomach and esophagus problems such as acid reflux and ulcer.
It works by reducing the amount of acid the stomach makes and providing relief from symptoms such as heartburn, difficulty swallowing, and cough.
This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers and is expected to help prevent cancer of the esophagus.
The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad, Zydus Lifesciences said.
USFDA gives approval for Nitisinone capsules
USFDA gives approval for Diazepam rectal gel
USFDA gives approval for Carboprost Tromethamine Injection
USFDA gives final approval for Ephedrine Sulfate Injection
USFDA gives approval for Brexpiprazole
Govt gives nod to sale of 2 rational FDC drugs
NPPA fixed retail price of 23 formulations: June 2023
Govt notifies MDR amendment for State Medical Devices Testing Laboratories
Cosmetics Testing in India: A Comprehensive Guide
Hyderabad Pharma City to become world’s largest pharma cluster: Minister
Jan Aushadhi Kendra: 2,000 more to open
Drug alert: This Typhoid Vaccine fails Quality Test – CDSCO
Govt Job: For M.Pharm, B.Pharm as Bench Chemist at CDSCO
Airlocks in the Pharma Industry: An essential component
Line clearance and maintenance in manufacturing: A comprehensive guide
